Home > Specialists > Breast Surgery > Dr. Songjie Shen (沈松杰)
Specialty & Clinical Focus:
Breast surgery specialist in Beijing at Peking Union Medical College Hospital (PUMCH), focusing on breast-conserving surgery, axillary-conserving procedures, immediate breast reconstruction, cosmetic tumor resection, and comprehensive breast cancer therapy.
Professional Title & Qualifications:
Chief Physician,
Professor,
Doctoral Supervisor
Hospital & Department：
Peking Union Medical College Hospital (PUMCH) - Department of Breast Surgery
(Note: PUMCH is consistently ranked as the #1 hospital in China)
(address: No. 1 Shuaifuyuan, Dongdan, Dongcheng District, Beijing, 100730)
Dr. Songjie Shen (沈松杰) - Breast Surgery Specialist
Personal Biography
Dr. Songjie Shen is a Chief Physician, Professor and doctoral supervisor in the Department of Breast Surgery at Peking Union Medical College Hospital (PUMCH) in Beijing. He serves as Deputy Director of the Breast Surgery Department and Director of the Ambulatory Care Center at the Xidan Campus. His clinical work focuses on the surgical and comprehensive management of benign and malignant breast diseases, including breast cancer surgery and reconstruction-related pathways.
Dr. Shen earned his M.D. and Ph.D. through Peking Union Medical College’s 8-year program in 2005. In 2013, he completed advanced study at Harvard Medical School, Dana-Farber Cancer Institute and the Harvard T.H. Chan School of Public Health. He also contributed to the Guidelines for Breast Cancer Screening for Chinese Women (2022 Edition), reflecting his role in breast cancer screening and clinical research in China.
Why Choose Dr. Songjie Shen (via MedBridgeNZ)
For international patients considering breast surgery or breast cancer care in China, Dr. Shen’s profile is relevant because his practice combines PUMCH breast-surgery experience with overseas academic training at Harvard Medical School and Dana-Farber Cancer Institute. His work spans breast-conserving surgery, axillary-conserving procedures, immediate reconstruction, cosmetic tumor resection, and comprehensive breast cancer therapy, making this page especially useful for patients who need organized case review before travel.
Before a remote specialist review or in-person appointment request, patients can prepare pathology reports, imaging, prior surgery or treatment history, and a focused question list. This creates a clearer basis for discussing potential surgical pathways, reconstruction considerations and hospital logistics in Beijing without overstating individual outcomes or appointment availability.
Pre-Travel Case Review & Specialist Liaison
Before committing to international travel for breast surgery, a pre-travel case review helps you organize your diagnosis, imaging, pathology, prior treatment history and key questions before Dr. Songjie Shen’s remote specialist-review pathway. Through MedBridgeNZ Limited, your records are prepared, translated where needed, and transferred with your authorization for specialist-review communication and appointment triage where available.
This process helps clarify the documents, questions and practical travel steps needed before you decide whether to continue with a PUMCH appointment request in Beijing. It is designed to support a more informed cross-border healthcare plan without implying appointment availability or a predetermined treatment pathway.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Songjie Shen
Areas of Expertise
Breast-Conserving Surgery: Advanced techniques to remove cancer while preserving the breast tissue.
Axillary-Conserving Surgery: Procedures designed to minimize lymph node removal and reduce post-operative complications.
Radical Mastectomy & Immediate Reconstruction: Comprehensive cancer removal combined with immediate aesthetic reconstruction for physical and psychological well-being.
Cosmetic Tumor Resection: Removal of benign or malignant tumors with a specialized focus on minimizing scarring.
Comprehensive Breast Cancer Therapy: Multidisciplinary management strategies for breast malignancies.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
4,600 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
2005 - Present: Department of Breast Surgery, Peking Union Medical College Hospital (PUMCH), Beijing.
2013: Visiting Fellow/Scholar, Harvard Medical School & Dana-Farber Cancer Institute, USA.
Current Roles: Deputy Director of Breast Surgery; Director of Day Care Center (West Campus), PUMCH.
Education & Training
M.D. & Ph.D., elite 8-year program, Peking Union Medical College (2005).
Advanced studies at Harvard Medical School, Dana-Farber Cancer Institute, and Harvard T.H. Chan School of Public Health, USA (2013).
Awards & Honors
Recipient of the Chinese Medical Science and Technology Award for clinical diagnostic and treatment achievements.
Recipient of the Beijing Science and Technology Award for clinical diagnostic and treatment achievements.
Academic & Professional Memberships
National Expert: National "Two Cancers" (Breast & Cervical) Screening Program.
Chair: Youth Committee of the Beijing Breast Disease Prevention Society.
Vice-Chair: Breast Cancer Prevention and Control Expert Committee, Beijing Health Promotion Association.
Vice-Chair: Cancer Early Screening, Diagnosis, and Treatment Subcommittee, Beijing Cancer Prevention and Control Research Society.
Research & Publications
Guideline Formulation: Lead drafter of the Guidelines for Breast Cancer Screening for Chinese Women (2022 Edition).
Translation Work: Lead translator of the authoritative text The Mayo Clinic Breast Cancer Book (Chinese Edition).
Selected Peer-Reviewed Publications
Selected peer-reviewed publications by Dr. Shen include:
Wang Y, et al. Comparison of ultrasound and mammography for early diagnosis of breast cancer among Chinese women with suspected breast lesions: A prospective trial. Thorac Cancer. 2022;13(22):3145-3151. PMID: 36177910
Song Y, et al. Adjuvant capecitabine in combination with docetaxel and cyclophosphamide versus anthracycline plus docetaxel and cyclophosphamide regimen in women with high-risk, HER2-negative breast cancer. Cancer Commun (Lond). 2025;45(9):1113-1122. PMID: 40491042
Shen S, et al. Cancer-derived exosomal miR-7641 promotes breast cancer progression and metastasis. Cell Commun Signal. 2021;19(1):20. PMID: 33618729
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
How can I request a remote specialist review with Dr. Shen before traveling to China?
A pre-travel remote specialist-review pathway helps international patients understand whether their records are ready for appointment triage at Peking Union Medical College Hospital. MedBridgeNZ coordinates medical-record preparation, translation support, client-authorized document transfer and appointment communication for Dr. Shen’s review pathway where available, so you can evaluate next steps before arranging medical travel to Beijing.
Is Dr. Shen’s expertise relevant to my breast surgery or breast cancer case?
Dr. Shen’s visible clinical focus includes breast-conserving surgery, axillary-conserving procedures, immediate reconstruction, cosmetic tumor resection and comprehensive breast cancer therapy. For a remote specialist-review pathway, submitted history, imaging, pathology, operative records and patient questions help the relevant specialist office review the case for appointment triage and provide specialist feedback or recommendations where available.
How does MedBridgeNZ manage logistics and language support if I travel to Beijing?
If an in-person pathway proceeds, MedBridgeNZ assists with appointment request communication, medical invitation or visa-document coordination support, travel planning, medical-record translation coordination and non-clinical bilingual administrative support. The goal is to make the patient journey to PUMCH more organized and easier to navigate while keeping hospital and specialist communications clear.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients seeking breast specialist-care pathways in China. We help with appointment request coordination, medical-record preparation, translation coordination, medical invitation or visa-document coordination support, travel planning and non-clinical bilingual administrative support. MedBridgeNZ does not provide medical advice, diagnosis or treatment, and third-party medical or travel costs remain separate unless expressly stated in writing.